Therefore, we first checked the proportion of round spermatids in testicular cell suspensions from males aged 18, 20, 22 and 24 days to define the optimal age for applying ROSI.
To define the optimal male age for spermatid collection, we first examined the proportion of round spermatids in cell suspensions collected from two males aged at 18, 20, 22, or 24 days.
The proportion of round or oval hypervascular nodules of under 2 cm which are later found to be HCCs has been variously reported as 5%, 13 %, 25, and 28%.
Using surface expression of the P28 antigen as a stage-specific marker, we quantified the proportion of round macrogametes and zygotes that developed into typically banana-shaped ookinetes.
However, the proportion of brush-like branched (type 3) cells per entire polar cell population (type 1 3; Fig. 6 J) or the proportion of round (type 4) cells per total number of examined cells (type 1 4; Fig. 6 K) was significantly increased when MGE cells overexpressed intact or genetically modified ErbB4.
In surface spreads obtained from Bscl2−/− males, a significant proportion of round spermatids (31.0%, P=0.032) exhibited fragmentation of the chromocenter into three or more heterochromatic foci as demonstrated by labeling with a bona fide marker for centromeric heterochromatin, H3K9me3 (histone H3 trimethylated at lysine 9), whereas this phenotype was detectable in only 7.1% of Bscl2+/+ control.
Thus, we calculated patient-specific classification error rates by identifying the proportion of CV rounds in which the patient was misclassified (see Figure 5 legend for additional details).
The bootstrap resampling procedure was repeated 10,000 times for each species and the achieved significance level was computed as the proportion of the rounds of bootstrap resampling for which this difference was equal to or greater than the difference obtained for the original data.
A proportion of small, round, yellow-coloured cells attached to the culture dish bottom (fibroblasts) and grew into bigger round cells with diameters of up to 60 μm.
HPV16 contributed to the greatest proportion of CIN2+ first-round population attributable proportion [PAR] 36%), followed by types 31, 52, 45, and 58 (7%–11%).
